Skip to content

A clinical study to study the drug Seenthil Sarkkarai on Neerizhivu

A Prospective open labelled Randomized Clinical trial on herbal formulation of â??Seenthil Sarkkaraiâ?? for the treatment of Iyaneerizhivu (Chronic Obstructive pulmonary Disease in patient with Type II Diabetes Mellitus )

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/01/011497
Enrollment
40
Registered
2018-01-23
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Iya Neerizhivu

Interventions

Intervention1: Seenthil Sarkkarai: 30 mg/ Kg/BW/daily three times a day With Ghee Control Intervention1: Not applicable: Not applicable

Sponsors

Dr S Neelavathi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Type 2 diabetes mellitus If yes in any of three FBS above 110 mg per dl and below and equal 250mg per dl or PPBS above 160 mg per dl and below and equal 350mg per dl HbA1c above 6.4 and below 10 Persistent cases of COPD as per the standard key indicators for assessment FEV1 between above 50 percentage and below 80 percentage of the predicted value Willing to give blood sample for the investigations Patients who are mono therapy alone

Exclusion criteria

Exclusion criteria: Age below 40 and above 70 Type 1 diabetes mellitus If yes in any of three FBS below 109 mg per dl and above and equal 251 mg per dl or PPBS below 159 mg per dl and above and equal 351 mg per dl HbA1c below 6.3 and above 10.1 FEV1 below 50 percentage and above 80 percentage of the predicted value Pregnant woman and plan to pregnant six months Lactating mother Chronic kidney disease or Renal failure Corticosteroid therapy Chronic active hepatitis or cirrhosis or ascites Multisystem involvement

Design outcomes

Secondary

MeasureTime frame
Evaluation of Siddha diagnostic parametersTimepoint: 90 days

Primary

MeasureTime frame
The therapeutic efficacy of trial drug Seenthil Sarkkarai on IYA NEERIZHIVUTimepoint: 90 days

Countries

India

Contacts

Public ContactDr A Manoharan MD Siddha

Government Siddha Medical college and hospital

drmanoharan25@gmail.com9443886700

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026